Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
Damiani, D
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. [electronic resource] - Leukemia Aug 1998 - 1236-40 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0887-6924
10.1038/sj.leu.2401092 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bilirubin--blood
Chemotherapy, Adjuvant
Creatinine--blood
Cyclosporine--adverse effects
Cytarabine--administration & dosage
Feasibility Studies
Female
Humans
Idarubicin--administration & dosage
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
Remission Induction
Treatment Outcome
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. [electronic resource] - Leukemia Aug 1998 - 1236-40 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0887-6924
10.1038/sj.leu.2401092 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bilirubin--blood
Chemotherapy, Adjuvant
Creatinine--blood
Cyclosporine--adverse effects
Cytarabine--administration & dosage
Feasibility Studies
Female
Humans
Idarubicin--administration & dosage
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged
Remission Induction
Treatment Outcome